Goat’s rue’s reputation as a natural remedy wanes amid weak evidence for breast milk and blood sugar claims

Despite its traditional use and biochemical links to diabetes medication, goat’s rue lacks robust scientific evidence to support claims of increasing breast milk or lowering blood sugar, with safety concerns prompting caution among healthcare professionals.

Goat’s rue has acquired an outsized reputation for a modest plant. Herbal sellers often promote it for two very different purposes: increasing breast milk and lowering blood sugar. Yet the evidence behind those claims is uneven, and the strongest part of the story is historical rather than therapeutic. According to the NIH’s LactMed database, goat’s rue contains galegine, a compound that helped inspire the development of metformin, one of the most important diabetes medicines in modern use. That connection is real; the leap from there to proving the herb works in people is not.

The plant itself, Galega officinalis, is a European legume long used in folk medicine and lactation support. WebMD and Drugs.com both note that it has been promoted for milk supply, weight control and blood sugar management, but also stress that scientific support is thin. LactMed is more blunt: goat’s rue is widely used as a galactagogue, yet there are no scientifically valid clinical trials showing that it reliably increases milk production on its own.

That matters because the breastfeeding evidence is often overstated. LactMed says galactagogues should not be used in place of proper assessment of latch, pumping patterns or other fixable causes of low supply. Drugs.com reaches the same conclusion and adds that goat’s rue’s best-known active compounds may contribute to hypoglycaemia, or low blood sugar. A small number of reports suggest possible benefit in combination products, but those studies do not isolate the herb itself, so they cannot show what goat’s rue contributed.

Claims that goat’s rue is a “natural metformin” are also more slogan than science. The herb does have a biochemical link to the drug, and Drugs.com and other reviews explain that metformin traces back to chemistry derived from galegine. But metformin is a purified, standardised prescription medicine tested in decades of clinical research, while goat’s rue is an unstandardised plant mixture. Any resemblance ends there. The blood sugar findings for goat’s rue come mainly from animal studies, not human trials, and there is no credible evidence that it should replace prescribed diabetes treatment.

Safety is another reason for caution. Reviews cited by Drugs.com and HelloPharmacist note that goat’s rue has caused toxicity in livestock, and animal studies have raised concerns about low blood pressure, paralysis and organ effects at high exposures. In people, the most immediate concern is that it may lower glucose too much, especially when taken with antidiabetic medication. Breastfeeding-specific safety data are limited, and reports involving mixed herbal products have included digestive upset and liver-related abnormalities.

For anyone considering goat’s rue, the practical answer is simple: treat it as an herb with a traditional use, not a proven treatment. There is no established human dose, and products vary widely in strength and composition. If a nursing mother is struggling with supply, the better first step is a lactation consultant. If someone has diabetes or prediabetes, any supplement that might affect blood sugar should be discussed with a clinician first. The historical link to metformin is interesting; the clinical case for goat’s rue, at least for now, remains weak.